| 标题 |
Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Jonathan I Silverberg; David Rosmarin; Thomas Bieber; Raj Chovatiya; Melinda Gooderham; et al 出版日期:2026-08-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)